Movers roundup: Rovi, Allergan

Movers roundup: Rovi shares fall on downgrade; Allergan shares fall

Associated Press

Among the stock activity stories for Monday, June 24, from AP Business News:

— Rovi Corp.'s shares dropped after a Pacific Crest Securities analyst downgraded his rating on digital TV listings company, citing concerns about limited growth potential.

— Shares of drug developer Allergan Inc. sank on the first full trading day after the Food and Drug Administration released a draft of guidance that could provide an easier-than-expected path to approval for a generic challenger to its eye treatment Restasis.

Rates

View Comments (0)